Desq Long
Sign in

Company

Tarsus Pharmaceuticals, Inc.

TARS · CIK 0001819790

SEC FORM 4
—

Tarsus Pharmaceuticals, Inc. (TARS)

Acquisition (code M) of 201 shares; price not stated (see filing).

Reporting Person PYOTT DAVID E I · Transaction Code M

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001051578-26-000010 · filed 2026-09-17 · View filing →

SEC FORM 4
—

Tarsus Pharmaceuticals, Inc. (TARS)

Acquisition (code M) of 302 shares; price not stated (see filing).

Reporting Person YARNO WENDY L · Transaction Code M

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001181186-26-000008 · filed 2026-09-17 · View filing →

SEC FORM 4
—

Tarsus Pharmaceuticals, Inc. (TARS)

Acquisition (code M) of 201 shares; price not stated (see filing).

Reporting Person LINK WILLIAM J PHD · Transaction Code M

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001228684-26-000010 · filed 2026-09-17 · View filing →

SEC FORM 4
$914,502.75

Tarsus Pharmaceuticals, Inc. (TARS)

Sale of 11,675 shares at $78.33 per share.

Reporting Person LINK WILLIAM J PHD · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001228684-26-000010 · filed 2026-09-17 · View filing →

SEC FORM 4
$59,961.00

Tarsus Pharmaceuticals, Inc. (TARS)

Sale of 759 shares at $79 per share.

Reporting Person LINK WILLIAM J PHD · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001228684-26-000010 · filed 2026-09-17 · View filing →

SEC FORM 4
$5,280.66

Tarsus Pharmaceuticals, Inc. (TARS)

Sale of 66 shares at $80.01 per share.

Reporting Person LINK WILLIAM J PHD · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001228684-26-000010 · filed 2026-09-17 · View filing →

SEC FORM 4
$387,940.00

Tarsus Pharmaceuticals, Inc. (TARS)

Sale of 4,564 shares at $85 per share.

Reporting Person Neervannan Seshadri · Officer Title Chief Operating Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001827584-26-000013 · filed 2026-09-09 · View filing →

SEC FORM 4
$640,917.00

Tarsus Pharmaceuticals, Inc. (TARS)

Sale of 7,100 shares at $90.27 per share.

Reporting Person Azamian Bobak R. · Officer Title President/CEO and Board Chair · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001827672-26-000013 · filed 2026-09-09 · View filing →

SEC FORM 4
$264,683.00

Tarsus Pharmaceuticals, Inc. (TARS)

Sale of 2,900 shares at $91.27 per share.

Reporting Person Azamian Bobak R. · Officer Title President/CEO and Board Chair · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001827672-26-000013 · filed 2026-09-09 · View filing →

SEC FORM 4
$457,895.00

Tarsus Pharmaceuticals, Inc. (TARS)

Sale of 5,387 shares at $85 per share.

Reporting Person Lin Elizabeth Yeu · Officer Title Chief Medical Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001842190-26-000011 · filed 2026-09-09 · View filing →

SEC FORM 4
$484,740.00

Tarsus Pharmaceuticals, Inc. (TARS)

Sale of 5,386 shares at $90 per share.

Reporting Person Lin Elizabeth Yeu · Officer Title Chief Medical Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001842190-26-000011 · filed 2026-09-09 · View filing →

SEC FORM 4
$135,150.00

Tarsus Pharmaceuticals, Inc. (TARS)

Sale of 1,590 shares at $85 per share.

Reporting Person Lin Elizabeth Yeu · Officer Title Chief Medical Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001842190-26-000011 · filed 2026-09-09 · View filing →

SEC FORM 4
$143,100.00

Tarsus Pharmaceuticals, Inc. (TARS)

Sale of 1,590 shares at $90 per share.

Reporting Person Lin Elizabeth Yeu · Officer Title Chief Medical Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001842190-26-000011 · filed 2026-09-09 · View filing →

SEC FORM 4
$800,600.00

Tarsus Pharmaceuticals, Inc. (TARS)

Sale of 10,000 shares at $80.06 per share.

Reporting Person Azamian Bobak R. · Officer Title President/CEO and Board Chair · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001827672-26-000011 · filed 2026-09-03 · View filing →

SEC FORM 4
$430,960.00

Tarsus Pharmaceuticals, Inc. (TARS)

Sale of 5,387 shares at $80 per share.

Reporting Person Lin Elizabeth Yeu · Officer Title Chief Medical Officer · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001842190-26-000009 · filed 2026-09-03 · View filing →

SEC FORM 4
$127,200.00

Tarsus Pharmaceuticals, Inc. (TARS)

Sale of 1,590 shares at $80 per share.

Reporting Person Lin Elizabeth Yeu · Officer Title Chief Medical Officer · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001842190-26-000009 · filed 2026-09-03 · View filing →

SEC FORM 4
$339,829.86

Tarsus Pharmaceuticals, Inc. (TARS)

Sale of 4,601 shares at $73.86 per share.

Reporting Person Lin Elizabeth Yeu · Officer Title Chief Medical Officer · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001842190-26-000009 · filed 2026-09-03 · View filing →